For up to date information, videos and support resources on COVID-19 from the Psychiatry Academy, click here.
Due to the Coronavirus pandemic, our staff and faculty will be working remotely.
Please email us with any questions at or call 866-644-7792 and leave a message.


Hammerness, Paul, MD

Scientific Coordinator, Pediatric ADHD Research, Clinical and Research Unit in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
Assistant Professor in Psychiatry, Harvard Medical School
Director, Child and Adolescent Psychiatry Clinic, Newton Wellesley Hospital


Dr. Paul Hammerness is Assistant Professor of Psychiatry, Harvard Medical School, Scientific Coordinator of Pediatric Attention Deficit Hyperactivity (ADHD) Research in the Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD of the Massachusetts General Hospital (MGH). Dr. Hammerness completed his Adult Psychiatry Residency and Fellowship in Child and Adolescent Psychiatry at the combined program of MGH-McLean Hospital.

Dr. Hammerness has been involved in over 100 research studies over the past 7 yrs in his work with the MGH group, he currently runs clinical research studies of pediatric and adult ADHD, and is involved in several areas of related study, including in depth cardiovascular investigations of ADHD pharmacotherapy, as well as neuroimaging, neuropsychological testing, and cognitive behavioral therapy for adolescents with ADHD.  Dr. Hammerness has lectured locally, nationally and internationally on the topic of ADHD, comorbidity and pediatric psychopharmacology. In addition, Dr. Hammerness is the Director of a part-time outpatient practice in general Child and Adolescent Psychiatry at Newton Wellesley Hospital, provides ongoing psychopharmacology consultation to a local pediatric group practice, is a Medical Editor for the MGH Academy, and has served on the MGH Institutional Review Board.